The latest learning and CPD content is categorised by asthma, COPD and respiratory tract infections. Under ‘Other resources’ you will find all our other content related to respiratory tract diseases.
Examining the impact of sub-optimal inhaler technique and how healthcare professionals can support patients in optimising their technique.
Inhaled corticosteroids: managing side effectsSubscription
Inhaled corticosteroids are commonly prescribed but need careful management to minimise the risk of side effects.
Asthma: long-term managementSubscription
Asthma management is based on a stepwise approach that should see medicines added or stopped based on patient symptoms.
Asthma: pathophysiology, causes and diagnosisSubscription
Despite asthma affecting more than 5.4 million people in the UK, there is no gold standard test and diagnosis is based on signs and symptoms.
Can someone start nicotine replacement therapy while taking theophylline to manage COPD?
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease: clinical phenotypes and implications for managementSubscription
Phenotyping patients with chronic obsructive pulmonary disease allows their separation into distinct categories that differentiate their prognosis and response to treatment, producing clinically meaningful outcomes.
Emergency oxygen treatment is used two million times a year by ambulance services, and almost one in five hospital patients in the UK are being treated with oxygen at any one time.
December 2010’s Lifelong Learning questions are based on the CLINICALFOCUS articles on Chronic obstructive pulmonary disease (COPD)The questions can be viewed/printedThis online module is closed
Stroke: classification and diagnosisSubscription
Slurred speech, facial droop and arm weakness — it is critical that all healthcare professionals are alert for these signs of stroke to ensure that patients displaying them receive treatment quickly
A pharmacist-led chronic obstructive pulmonary disease clinic has led to remarkably improved outcomes for patients in the north east of England, and has shown some unexpected benefits.Ailsa Colquhoun spoke to the clinical pharmacist responsibleSee Best practice
Respiratory tract infections
The COVID-19 pandemic has highlighted the importance of understanding the differences between viral and bacterial pneumonia, and how adult patients can be managed as they recover at home.
Case-based learning: sore throatSubscription
Most sore throats are caused by viral infections and get better within a week through self-care. However, it is important to recognise when a sore throat is a symptom of a more serious illness.
Case-based learning: cough Subscription
Most coughs are acute and self-limiting; however, it is important to understand when a cough becomes clinically significant.
Pharmacists can play a vital role in the diagnosis and management of idiopathic pulmonary fibrosis, and can help improve outcomes and the burden of disease.
Hospital‑acquired pneumonia increases the length of in-patient hospital stay and is associated with high mortality rates, particularly in older people. Pharmacists and healthcare professionals need to know how to diagnose and manage the condition, and be cognisant of the gaps in the evidence base.
Bronchiectasis is a common chronic disease where the airways of the lungs become abnormally widened. Patients present with recurrent cough, sputum production and are at risk of respiratory tract infections. Pharmacists and healthcare professionals need to be aware of the latest management strategies.
What is amyotrophic lateral sclerosis?Subscription
The ‘ice bucket challenge’ was started to raise awareness of ALS; find out more about this fatal neurodegenerative condition.
Pneumonia: CAP, HAP and other typesSubscription
Pneumonia is one of the leading causes of mortality with four million deaths worldwide each year. This article consolidates your knowledge of symptoms, diagnosis and treatment
Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.
Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research findsSubscription
A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.
Once-daily ICS-LABA-LAMA superior to ICS-LABA in improving lung function, research suggestsSubscription
A study in The Lancet Respiratory Medicine indicates that ICS-LABA-LAMA once daily is better than ICS-LABA in improving lung function.
Blue, brown and now greenSubscription
The ‘NHS long-term plan’ has called for a shift towards inhalers with a lower carbon footprint.
Women with asthma who experience exacerbations during pregnancy are more likely to have birth complications than women with well-controlled asthma, a study published in the European Respiratory Journal has suggested.
Switching patients who use metered-dose inhalers, which contain hydrofluoroalkane propellants, to cheaper, more environmentally friendly alternatives could lead to major cost savings, as well as reduced NHS greenhouse gas emissions.
Switching inhalers can boost adherenceSubscription
Inhaler switching in asthma and COPD is not associated with negative impacts on patients’ health, study results published in Thorax have shown.
A previously reported association between analgesic use in pregnancy and childhood asthma is likely to result from confounding factors, researchers have concluded.
Daily multidisciplinary team (MDT) meetings significantly reduced the length of hospital stay for patients with COPD, a study published in the Journal of the American Osteopathic Association has found.
Point-of-care C-reactive protein testing reduces antibiotic use in people with acute COPD exacerbations, a study published in The New England Journal of Medicine has shown.
Triple therapy reduces the number of moderate-to-severe exacerbations in people with chronic obstructive pulmonary disease, a study presented at the CHEST annual meeting has shown.
There is a lack of ‘convincing’ evidence that statins improve outcomes in non-cardiovascular conditions, such as diabetes, a review has shown.
Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary diseaseSubscription
A review of the current evidence, including the safety and efficacy of dual and triple-combination inhalers for the treatment of stable COPD, and their place in therapy.
Study shows that current smokers, aged 60 years or older, had a 60% greater odds of becoming frail during follow-up compared with non-smokers.
Many patients who contract COVID-19 have detectable lung dysfunction 12 weeks after hospital discharge, results have suggested.
Honey is superior to usual care for improving symptoms of upper respiratory tract infection symptoms, researchers have concluded.
The COVID-19 pandemic has been a huge challenge, but it has revolutionised pharmacy practice in some positive ways. In the first of a three-part series, we ask hospital pharmacists which changes they want to retain.
Enzyme mouth spray could shorten cold durationSubscription
An oral spray containing a proteolytic enzyme reduced the severity and duration of the common cold, a randomised study has found.
Analysis of children presenting in primary care has found that delaying or withholding antibiotics is the most appropriate way of treating suspected respiratory tract infections.